PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 142 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2018. The put-call ratio across all filers is 1.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $61,296 | -70.5% | 19,837 | -59.7% | 0.00% | -75.0% |
| Q4 2022 | $208,082 | +383.9% | 49,192 | +169.1% | 0.00% | +300.0% |
| Q3 2022 | $43,000 | -85.5% | 18,283 | -82.5% | 0.00% | -87.5% |
| Q2 2022 | $297,000 | -52.9% | 104,223 | -52.4% | 0.01% | -52.9% |
| Q1 2022 | $630,000 | -48.6% | 218,917 | -45.7% | 0.02% | -55.3% |
| Q4 2021 | $1,225,000 | +402.0% | 403,119 | +1350.1% | 0.04% | +137.5% |
| Q4 2019 | $244,000 | -35.6% | 27,800 | -6.7% | 0.02% | -61.9% |
| Q2 2019 | $379,000 | +205.6% | 29,800 | +1001.3% | 0.04% | -27.6% |
| Q3 2018 | $124,000 | – | 2,706 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |